| Literature DB >> 36160327 |
Aryan Shamili1,2, Afsoon Hassani Mehraban1, Akram Azad1, Gholam Reza Raissi3, Mohsen Shati4.
Abstract
Introduction: Action observation therapy (AOT) is a mirror neuron-based approach that has been recently used in poststroke rehabilitation. The main goal of this study was to investigate the effectiveness of AOT of occupations and tasks that are meaningful for chronic stroke patients on occupational performance, upper-extremity function, and corticospinal changes. Method: A randomized control trial was designed to compare between experimental (n = 13) and control groups (n = 14). In both groups, the execution of meaningful tasks was practiced, but the videos of those tasks were just shown to the experiment group. Instead, patients in the control group watched nature videos as a placebo. Clinical outcomes were evaluated using the Canadian Occupational Performance Measure (COPM), Fugl-Meyer Assessment (FMA), Action Research Arm Test (ARAT), and Box-Block Test (BBT) on 3 occasions: baseline, post (at 4 weeks), and follow-up (at 8 weeks). The assessments of central motor conduction time (CMCT) for abductor policis brevis (APB) and extensor indicis (EI) were only recorded at baseline and posttreatment. Both assessors of clinical and neurophysiological outcomes were blinded to the allocation of subjects. Result: Finally, the results of outcomes in 24 patients who completed the study were analyzed. In both groups, significant improvements after treatment were seen for most outcomes (p ≤ 0.05). These changes were persistent until follow-up. There were significant differences in COPM performance (p = 0.03) and satisfaction (p = 0.001) between the experimental and control groups. In contrast, other clinical assessments such as FMA, ARAT, and BBT did not show significant differences between the two treatments (p ≥ 0.05). The results of CMCT related to APB showed a more significant change in the experiment group compared to the control group (p = 0.022). There was no difference in change detected between the two groups for CMCT related to EI after treatments.Entities:
Mesh:
Year: 2022 PMID: 36160327 PMCID: PMC9507745 DOI: 10.1155/2022/5284044
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.144
Figure 1Flowchart of the participants included in the study.
Eating-related meaningful tasks (I–IV), their subtasks, and the procedure time.
| Task | ||||||
|---|---|---|---|---|---|---|
| Subtask | Task I | Task II | Task III | Task IV |
|
|
| A | Reach to the bottle | Reach to the spoon and fork | Reach to the glass | Reach to the fork | 2 m | 3 m |
| B | Grasp the bottle | Grasp the spoon and fork | Grasp the glass | Grasp the fork | 2 m | 3 m |
| C | Bring the bottle near to the glass | Take some meal | Bring the glass near to the mouth | Bring the fork near to the carrot | 2 m | 3 m |
| D | Pour water into glass | Bring spoon to mouth and eat | Drink from the glass | Bring the carrot to the mouth | 2 m | 3 m |
| E | Reach out to desktop | Reach out and place spoon and fork beside the plate | Reach out to the desktop | Reach out to the dish | 2 m | 3 m |
| F | Release the bottle | Release the spoon and fork | Release the glass | Release the fork | 2 m | 3 m |
| G | Rest arm | Rest arm | Rest arm | Rest arm | 2 m | 3 m |
| H | Whole task | Whole task | Whole task | Whole task | 2 m | 3 m |
∗Films in AOT includes videos of a model performing the A-H subtasks for intervention group. ∗∗ Films in sham include videos of nature and landscapes for control group. m: minute; whole task: the combination of subtasks A–G.
Figure 2A left hemiplegic patient in AOT group watching AOT videos of (a) lateral view, (b) point of view, and (c) front view.
Figure 3A right hemiplegic patient in control group watching landscape (sham) videos.
Distribution of demographic variables in the intervention and control groups.
| Qualitative variables | Intervention ( | Control ( |
|---|---|---|
| Sex |
|
|
| Female | 5 (41.7%) | 3 (25%) |
| Male | 7 (58.3%) | 9 (75%) |
| Type of stroke | ||
| Hemorrhagic | 4 (33.3%) | 2 (16.7%) |
| Ischemic | 8 (66.7%) | 10 (83.3) |
| Affected side | ||
| Right | 5 (41.7%) | 6 (50%) |
| Left | 7 (58.3%) | 6 (50%) |
| Handedness | ||
| Right | 11 (91.7%) | 10 (83.3%) |
| Left | 1 (8.3%) | 2 (16.7%) |
| Upper arm Brunnstrom stage | ||
| III | 3 (25%) | 4 (33.3%) |
| IV | 6 (50%) | 2(16.7%) |
| V | 3 (25%) | 6 (50%) |
| Hand Brunnstrom stage | ||
| III | 4 (33.3%) | 4 (33.3%) |
| IV | 6 (50%) | 3 (25%) |
| V | 2 (16.7%) | 5 (41.7%) |
| Motor evoked potential (APB) | ||
| + | 6 (50%) | 7 (58.3%) |
| − | 6 (50%) | 5 (41.7%) |
| Quantitative variables | Intervention ( | Control ( |
| Mean ± SD | Mean ± SD | |
| Age (year) | 53.5 ± 10.55 | 56.58 ± 11.21 |
| Time since stroke (month) | 39.75 ± 28.35 | 42.58 ± 29.25 |
Pre, post, and follow-up outcome measures of the intervention and control groups (time × group interaction).
| Baseline | Post (at 4 weeks) | Follow-up (at 8 weeks) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||||||
| Intervention | Control ( | Intervention ( | Control ( | Intervention ( | Control ( | Wilks lambda |
|
| Effect size (Eta2) | |
| COPM (performance) | 3.00 ± 1.34 | 3.41 ± 2.35 | 6.58 ± 2.02 | 5.29 ± 2.43 | 6.50 ± 1.97 | 5.37 ± 2.44 | 0.73 | 3.83 | 0.03∗ | 0.26 |
| COPM (satisfaction) | 2.75 ± 1.76 | 3.66 ± 2.60 | 6.58 ± 2.46 | 4.83 ± 2.48 | 6.66 ± 2.38 | 4.91 ± 2.39 | 0.50 | 10.36 | 0.001∗ | 0.49 |
| Actual task performance | 19.41 ± 13.96 | 23.08 ± 11.07 | 29.00 ± 15.67 | 28.75 ± 11.81 | 29.00 ± 15.40 | 28.08 ± 11.95 | 0.73 | 3.71 | 0.042∗ | 0.26 |
| FMA-UE | 38.66 ± 12.57 | 41.33 ± 14.53 | 46.16 ± 7.1 | 46.41 ± 12.0 | 46.33 ± 14.72 | 46.66 ± 12.68 | 0.91 | 0.96 | 0.39 | 0.08 |
| ARAT | 23.08 ± 24.18 | 25.83 ± 19.78 | 27.00 ± 23.41 | 30.16 ± 20.70 | 26.83 ± 23.53 | 29.58 ± 20.76 | 0.96 | 0.41 | 0.66 | 0.03 |
| BBT | 9.82 ± 12.22 | 12.38 ± 10.45 | 13.16 ± 15.48 | 13.46 ± 10.95 | 13.08 ± 15.52 | 13.25 ± 11.19 | 0.88 | 1.37 | 0.275 | 0.11 |
Note: ∗ = statistically significant; COPM: Canadian Occupational Performance Measure; F: test for repeated measures 2-way ANOVA; FMA-UE: Fugl-Meyer Assessment (upper extremity); ARAT: Action Research Arm Test; BBT: Box and Block Test.
MEP comparison between the intervention and control groups, before and after the therapy.
| Baseline Mean ± SD | Post (at 4 weeks) Mean ± SD | Mean change ± SD | Mann-Whitney test |
| ||||
|---|---|---|---|---|---|---|---|---|
| CMCT (APB) | Intervention ( | Control ( | Intervention ( | Control ( | Intervention ( | Control ( | ||
| 12.41 ± 3.15 | 13.24 ± 2.05 | 10.20 ± 2.20 | 13.24 ± 1.68 | −2.21 ± 2.32 | 0.00 ± 1.01 | −2.29 | 0.022∗ | |
|
| ||||||||
| CMCT (EI) | Intervention ( | Control ( | Intervention ( | Control ( | Intervention ( | Control ( | −0.48 | 0.625 |
| 12.38 ± 4.10 | 14.60 ± 4.59 | 11.42 ± 2.00 | 13.75 ± 3.40 | −0.96 ± 2.04 | −0.84 ± 2.88 | |||
∗ = statistically significant; MEP: motor evoked potential; CMCT: central motor conduction time; APB: abductor policis brevis; EI: extensor indicis.